Takeda to Transfer Spikevax Authorization to Moderna in Japan, 3-Way Purchase Deal to End

Takeda Pharmaceutical said on May 31 that it will hand over Japanese marketing authorization for Moderna’s COVID-19 vaccine Spikevax to the US partner as of August 1. Trilateral supply pacts signed with the Japanese government will be terminated, also effective...read more